In the last 12 months, insiders at OnKure Therapeutics, Inc. ($OKUR) filed 89 transactions with the SEC: 14 open-market purchases totaling $5,315,495 and 16 sales totaling $4,235,524. Net insider sentiment: net buying.
OnKure Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Cormorant Asset Management, LP (Not found) — 2 transactions totaling $3,411,258
- ACORN BIOVENTURES, L.P. (Not found) — 2 transactions totaling $2,590,000
- Leonard Braden Michael (Not found) — 13 transactions totaling $1,725,495
- O'Donnell Niall (Director) — 2 transactions totaling $1,000,000
- Novo Holdings A/S (TenPercentOwner) — 1 transaction totaling $709,740
View all SEC Filings for OnKure Therapeutics, Inc. (OKUR).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Saccomano Nicholas A | President and CEO | A | Employee Stock Option (right to buy) | 330000 | $0.00 | 330,000.0000 | 13,530,892 | 9999.99% | 2.44% |
| April 1, 2026 | Leverone Jason A. | Chief Financial Officer | A | Employee Stock Option (right to buy) | 110000 | $0.00 | 110,000.0000 | 13,530,892 | 9999.99% | 0.81% |
| April 1, 2026 | Hartley Dylan | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 110000 | $0.00 | 110,000.0000 | 13,530,892 | 9999.99% | 0.81% |
| April 1, 2026 | Agresta Samuel | Chief Medical Officer | A | Employee Stock Option (right to buy) | 110000 | $0.00 | 110,000.0000 | 13,530,892 | 9999.99% | 0.81% |
| March 31, 2026 | Ratcliffe Liam | Not found | A | Stock Option (right to buy) | 15300 | $0.00 | 15,300.0000 | 13,530,892 | 9999.99% | 0.11% |
| March 23, 2026 | Saccomano Nicholas A | President and CEO | S | Class A Common Stock | 86 | $4.16 | 7,333.0000 | 13,530,892 | 1.16% | 0.00% |
| March 23, 2026 | Leverone Jason A. | Chief Financial Officer | S | Class A Common Stock | 301 | $4.16 | 16,000.0000 | 13,530,892 | 1.85% | 0.00% |
| Dec. 31, 2025 | Mathers Edward T | Not found | A | Class A Common Stock | 3911 | $0.00 | 15,310.0000 | 13,530,892 | 34.31% | 0.03% |
| Dec. 31, 2025 | Manke Isaac | Not found | A | Class A Common Stock | 5258 | $0.00 | 20,583.0000 | 13,530,892 | 34.31% | 0.04% |
| Dec. 22, 2025 | Leverone Jason A. | Chief Financial Officer | S | Class A Common Stock | 302 | $2.97 | 16,301.0000 | 13,530,892 | 1.82% | 0.00% |
| Dec. 22, 2025 | Saccomano Nicholas A | President and CEO | S | Class A Common Stock | 87 | $2.97 | 7,419.0000 | 13,530,892 | 1.16% | 0.00% |
| Sept. 30, 2025 | Manke Isaac | Not found | A | Class A Common Stock | 5545 | $0.00 | 15,325.0000 | 3,447,071 | 56.70% | 0.16% |
| Sept. 30, 2025 | Mathers Edward T | Not found | A | Class A Common Stock | 4125 | $0.00 | 11,399.0000 | 3,447,071 | 56.71% | 0.12% |
| Sept. 22, 2025 | Leverone Jason A. | Chief Financial Officer | S | Class A Common Stock | 303 | $2.62 | 12,603.0000 | 3,447,071 | 2.35% | 0.01% |
| Sept. 22, 2025 | Saccomano Nicholas A | President and CEO | S | Class A Common Stock | 88 | $2.62 | 3,506.0000 | 3,447,071 | 2.45% | 0.00% |
| June 30, 2025 | Manke Isaac | Not found | A | Class A Common Stock | 6311 | $0.00 | 9,780.0000 | 3,447,071 | 181.93% | 0.18% |
| June 30, 2025 | Mathers Edward T | Not found | A | Class A Common Stock | 4694 | $0.00 | 7,274.0000 | 3,447,071 | 181.94% | 0.14% |
| June 23, 2025 | Leverone Jason A. | Chief Financial Officer | S | Class A Common Stock | 303 | $2.38 | 12,906.0000 | 3,447,071 | 2.29% | 0.01% |
| June 23, 2025 | Saccomano Nicholas A | President and CEO | S | Class A Common Stock | 88 | $2.38 | 3,594.0000 | 3,447,071 | 2.39% | 0.00% |
| May 28, 2025 | Phillips Andrew John | Not found | A | Stock Option (right to buy) | 7650 | $0.00 | 7,650.0000 | 3,447,071 | 9999.99% | 0.22% |
| May 28, 2025 | Mathers Edward T | Not found | A | Stock Option (right to buy) | 7650 | $0.00 | 7,650.0000 | 3,447,071 | 9999.99% | 0.22% |
| May 28, 2025 | Manke Isaac | Not found | A | Stock Option (right to buy) | 7650 | $0.00 | 7,650.0000 | 3,447,071 | 9999.99% | 0.22% |
| May 28, 2025 | Jansen Valerie Malyvanh | Not found | A | Stock Option (right to buy) | 7650 | $0.00 | 7,650.0000 | 3,447,071 | 9999.99% | 0.22% |
| May 28, 2025 | GREY MICHAEL G | Not found | A | Stock Option (right to buy) | 7650 | $0.00 | 7,650.0000 | 3,447,071 | 9999.99% | 0.22% |
| May 28, 2025 | Carruthers R Michael | Not found | A | Stock Option (right to buy) | 7650 | $0.00 | 7,650.0000 | 3,447,071 | 9999.99% | 0.22% |
| May 15, 2025 | Cormorant Asset Management, LP | Not found | S | Class A Common Stock | 1813439 | $1.85 | 0.0000 | 3,447,071 | 100.00% | 52.61% |
| May 15, 2025 | ACORN BIOVENTURES, L.P. | Not found | P | Common Stock | 1129730 | $1.85 | 2,839,674.0000 | 3,447,071 | 66.07% | 32.77% |
| May 15, 2025 | ACORN BIOVENTURES, L.P. | Not found | P | Common Stock | 270270 | $1.85 | 2,839,674.0000 | 3,447,071 | 10.52% | 7.84% |
| May 12, 2025 | Cormorant Asset Management, LP | Not found | S | Class A Common Stock | 24300 | $1.99 | 1,813,439.0000 | 3,447,071 | 1.32% | 0.70% |
| April 7, 2025 | Saccomano Nicholas A | President and CEO | S | Class A Common Stock | 516 | $2.67 | 3,682.0000 | 3,447,071 | 12.29% | 0.01% |
| April 7, 2025 | Leverone Jason A. | Chief Financial Officer | S | Class A Common Stock | 1844 | $2.67 | 13,209.0000 | 3,447,071 | 12.25% | 0.05% |
| April 4, 2025 | Saccomano Nicholas A | President and CEO | S | Class A Common Stock | 358 | $3.33 | 4,198.0000 | 3,447,071 | 7.86% | 0.01% |
| April 4, 2025 | Leverone Jason A. | Chief Financial Officer | S | Class A Common Stock | 1278 | $3.33 | 15,053.0000 | 3,447,071 | 7.83% | 0.04% |
| March 31, 2025 | Manke Isaac | Not found | A | Class A Common Stock | 3469 | $0.00 | 3,469.0000 | 3,447,071 | 9999.99% | 0.10% |
| March 31, 2025 | Mathers Edward T | Not found | A | Class A Common Stock | 2580 | $0.00 | 2,580.0000 | 3,447,071 | 9999.99% | 0.07% |
| Jan. 27, 2025 | Saccomano Nicholas A | President and CEO | A | Employee Stock Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 3,447,071 | 9999.99% | 3.77% |
| Jan. 27, 2025 | Hartley Dylan | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 3,447,071 | 9999.99% | 1.31% |
| Jan. 27, 2025 | Leverone Jason A. | Chief Financial Officer | A | Employee Stock Option (right to buy) | 65000 | $0.00 | 65,000.0000 | 3,447,071 | 9999.99% | 1.89% |
| Jan. 27, 2025 | Agresta Samuel | Chief Medical Officer | A | Employee Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 3,447,071 | 9999.99% | 1.31% |
| Oct. 7, 2024 | Leonard Braden Michael | Not found | J | Common Stock | 345739 | $0.00 | 447,815.0000 | 316,142 | 338.71% | 100.00% |
| Oct. 7, 2024 | Leonard Braden Michael | Not found | J | Common Stock | 102076 | $0.00 | 447,815.0000 | 316,142 | 29.52% | 32.29% |
| Oct. 4, 2024 | Mathers Edward T | Not found | A | Stock Option (right to buy) | 15300 | $0.00 | 15,300.0000 | 316,142 | 9999.99% | 4.84% |
| Oct. 4, 2024 | Saccomano Nicholas A | President and CEO | A | Class A Common Stock | 4556 | $0.00 | 4,556.0000 | 316,142 | 9999.99% | 1.44% |
| Oct. 4, 2024 | Saccomano Nicholas A | President and CEO | A | Employee Stock Option (right to buy) | 2359 | $0.00 | 2,359.0000 | 316,142 | 9999.99% | 0.75% |
| Oct. 4, 2024 | Saccomano Nicholas A | President and CEO | A | Employee Stock Option (right to buy) | 1485 | $0.00 | 1,485.0000 | 316,142 | 9999.99% | 0.47% |
| Oct. 4, 2024 | Saccomano Nicholas A | President and CEO | A | Employee Stock Option (right to buy) | 16898 | $0.00 | 16,898.0000 | 316,142 | 9999.99% | 5.35% |
| Oct. 4, 2024 | Saccomano Nicholas A | President and CEO | A | Employee Stock Option (right to buy) | 8449 | $0.00 | 8,449.0000 | 316,142 | 9999.99% | 2.67% |
| Oct. 4, 2024 | Saccomano Nicholas A | President and CEO | A | Employee Stock Option (right to buy) | 542232 | $0.00 | 542,232.0000 | 316,142 | 9999.99% | 100.00% |
| Oct. 4, 2024 | Phillips Andrew John | Not found | A | Stock Option (right to buy) | 15300 | $0.00 | 15,300.0000 | 316,142 | 9999.99% | 4.84% |
| Oct. 4, 2024 | Manke Isaac | Not found | A | Stock Option (right to buy) | 15300 | $0.00 | 15,300.0000 | 316,142 | 9999.99% | 4.84% |
| Oct. 4, 2024 | Leverone Jason A. | Chief Financial Officer | A | Class A Common Stock | 16331 | $0.00 | 16,331.0000 | 316,142 | 9999.99% | 5.17% |
| Oct. 4, 2024 | Leverone Jason A. | Chief Financial Officer | A | Employee Stock Option (right to buy) | 5781 | $0.00 | 5,781.0000 | 316,142 | 9999.99% | 1.83% |
| Oct. 4, 2024 | Leverone Jason A. | Chief Financial Officer | A | Employee Stock Option (right to buy) | 5322 | $0.00 | 5,322.0000 | 316,142 | 9999.99% | 1.68% |
| Oct. 4, 2024 | Leverone Jason A. | Chief Financial Officer | A | Employee Stock Option (right to buy) | 130611 | $0.00 | 130,611.0000 | 316,142 | 9999.99% | 41.31% |
| Oct. 4, 2024 | Jansen Valerie Malyvanh | Not found | A | Stock Option (right to buy) | 15300 | $0.00 | 15,300.0000 | 316,142 | 9999.99% | 4.84% |
| Oct. 4, 2024 | Hartley Dylan | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 137603 | $0.00 | 137,603.0000 | 316,142 | 9999.99% | 43.53% |
| Oct. 4, 2024 | GREY MICHAEL G | Not found | A | Stock Option (right to buy) | 15300 | $0.00 | 15,300.0000 | 316,142 | 9999.99% | 4.84% |
| Oct. 4, 2024 | Carruthers R Michael | Not found | A | Class A Common Stock | 874 | $0.00 | 874.0000 | 316,142 | 9999.99% | 0.28% |
| Oct. 4, 2024 | Carruthers R Michael | Not found | A | Class A Common Stock | 4065 | $0.00 | 4,939.0000 | 316,142 | 465.10% | 1.29% |
| Oct. 4, 2024 | Carruthers R Michael | Not found | A | Stock Option (right to buy) | 1760 | $0.00 | 1,760.0000 | 316,142 | 9999.99% | 0.56% |
| Oct. 4, 2024 | Carruthers R Michael | Not found | A | Stock Option (right to buy) | 1324 | $0.00 | 1,324.0000 | 316,142 | 9999.99% | 0.42% |
| Oct. 4, 2024 | Carruthers R Michael | Not found | A | Stock Option (right to buy) | 15300 | $0.00 | 15,300.0000 | 316,142 | 9999.99% | 4.84% |
| Oct. 4, 2024 | Agresta Samuel | Chief Medical Officer | A | Employee Stock Option (right to buy) | 18588 | $0.00 | 18,588.0000 | 316,142 | 9999.99% | 5.88% |
| Oct. 4, 2024 | Agresta Samuel | Chief Medical Officer | A | Employee Stock Option (right to buy) | 131396 | $0.00 | 131,396.0000 | 316,142 | 9999.99% | 41.56% |
| Sept. 24, 2024 | Leonard Braden Michael | Not found | P | Common Stock | 29600 | $1.41 | 4,409,418.0000 | 283,817 | 0.68% | 10.43% |
| Sept. 25, 2024 | Leonard Braden Michael | Not found | P | Common Stock | 68746 | $1.50 | 4,478,164.0000 | 283,817 | 1.56% | 24.22% |
| Sept. 18, 2024 | Leonard Braden Michael | Not found | P | Common Stock | 806 | $1.40 | 4,379,818.0000 | 283,817 | 0.02% | 0.28% |
| Sept. 17, 2024 | Leonard Braden Michael | Not found | P | Common Stock | 55300 | $1.36 | 4,379,012.0000 | 283,817 | 1.28% | 19.48% |
| Sept. 13, 2024 | Leonard Braden Michael | Not found | P | Common Stock | 150000 | $1.31 | 4,150,965.0000 | 283,817 | 3.75% | 52.85% |
| Sept. 12, 2024 | Leonard Braden Michael | Not found | P | Common Stock | 36176 | $1.40 | 4,000,965.0000 | 283,817 | 0.91% | 12.75% |
| Sept. 16, 2024 | Leonard Braden Michael | Not found | P | Common Stock | 172747 | $1.37 | 4,323,712.0000 | 283,817 | 4.16% | 60.87% |
| Aug. 13, 2024 | Leonard Braden Michael | Not found | P | Common Stock | 171339 | $1.39 | 3,864,302.0000 | 283,817 | 4.64% | 60.37% |
| Aug. 14, 2024 | Leonard Braden Michael | Not found | P | Common Stock | 100487 | $1.41 | 3,964,789.0000 | 283,817 | 2.60% | 35.41% |
| May 14, 2024 | Leonard Braden Michael | Not found | P | Common Stock | 79281 | $1.56 | 3,357,963.0000 | 283,817 | 2.42% | 27.93% |
| May 14, 2024 | Leonard Braden Michael | Not found | P | Common Stock | 335000 | $1.54 | 3,692,963.0000 | 283,817 | 9.98% | 100.00% |
| Aug. 28, 2023 | Hall Ashley | Chief Development Officer | M | Common Stock | 15625 | $1.80 | 55,225.0000 | 0 | 39.46% | 0.00% |
| Aug. 28, 2023 | Hall Ashley | Chief Development Officer | S | Common Stock | 15625 | $6.28 | 39,600.0000 | 0 | 28.29% | 0.00% |
| Aug. 28, 2023 | Hall Ashley | Chief Development Officer | M | Stock option (right to buy) | 15625 | $0.00 | 109,375.0000 | 0 | 12.50% | 0.00% |
| July 26, 2023 | GREY MICHAEL G | Executive Chairman | G | Common Stock | 50000 | $0.00 | 628,846.0000 | 0 | 7.37% | 0.00% |
| June 23, 2023 | Novo Holdings A/S | TenPercentOwner | S | Common Stock | 100000 | $7.10 | 3,330,337.0000 | 0 | 2.92% | 0.00% |
| June 6, 2023 | Seltzer Stacey Denenberg | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | O'Donnell Niall | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | Muralidhar Bali | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | GREY MICHAEL G | Executive Chairman | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | Blunt Roshawn A. | Director | A | Stock Option (right to buy) | 14815 | $0.00 | 14,815.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | Mathers Edward T | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 0 | 50.00% | 0.00% |
| June 6, 2023 | Hoelscher Paul W. | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | Dube Eric M | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| May 8, 2023 | O'Donnell Niall | Director | P | Common Stock | 125000 | $8.00 | 2,188,713.0000 | 0 | 6.06% | 0.00% |